These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 14738461)

  • 1. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
    Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
    Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.
    Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M
    Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA.
    Wirtz S; Becker C; Blumberg R; Galle PR; Neurath MF
    J Immunol; 2002 Jan; 168(1):411-20. PubMed ID: 11751987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.
    Wang H; Dong J; Shi P; Liu J; Zuo L; Li Y; Gong J; Gu L; Zhao J; Zhang L; Zhang W; Zhu W; Li N; Li J
    Immunology; 2015 Feb; 144(2):254-62. PubMed ID: 25087772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo.
    Holtmann MH; Douni E; Schütz M; Zeller G; Mudter J; Lehr HA; Gerspach J; Scheurich P; Galle PR; Kollias G; Neurath MF
    Eur J Immunol; 2002 Nov; 32(11):3142-51. PubMed ID: 12555659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.
    Stallmach A; Marth T; Weiss B; Wittig BM; Hombach A; Schmidt C; Neurath M; Zeitz M; Zeuzem S; Abken H
    Gut; 2004 Mar; 53(3):339-45. PubMed ID: 14960512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.
    Melgar S; Yeung MM; Bas A; Forsberg G; Suhr O; Oberg A; Hammarstrom S; Danielsson A; Hammarstrom ML
    Clin Exp Immunol; 2003 Oct; 134(1):127-37. PubMed ID: 12974765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
    Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
    Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
    Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice.
    Ten Hove T; Corbaz A; Amitai H; Aloni S; Belzer I; Graber P; Drillenburg P; van Deventer SJ; Chvatchko Y; Te Velde AA
    Gastroenterology; 2001 Dec; 121(6):1372-9. PubMed ID: 11729116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria.
    Hvas CL; Kelsen J; Agnholt J; Höllsberg P; Tvede M; Møller JK; Dahlerup JF
    Scand J Gastroenterol; 2007 May; 42(5):592-601. PubMed ID: 17454880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.
    Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W
    J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.
    Bourreille A; Doubremelle M; de la Blétière DR; Segain JP; Toquet C; Buelow R; Galmiche JP
    Scand J Gastroenterol; 2003 May; 38(5):526-32. PubMed ID: 12795464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis.
    Mudter J; Wirtz S; Galle PR; Neurath MF
    Pathobiology; 2002-2003; 70(3):170-6. PubMed ID: 12571422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis.
    Terabe F; Fujimoto M; Serada S; Shinzaki S; Iijima H; Tsujii M; Hayashi N; Nomura S; Kawahata H; Jang MH; Miyasaka M; Mihara M; Ohsugi Y; Kishimoto T; Naka T
    Inflamm Bowel Dis; 2011 Feb; 17(2):491-502. PubMed ID: 20602470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.
    Matsuoka K; Inoue N; Sato T; Okamoto S; Hisamatsu T; Kishi Y; Sakuraba A; Hitotsumatsu O; Ogata H; Koganei K; Fukushima T; Kanai T; Watanabe M; Ishii H; Hibi T
    Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-gamma and TNF-alpha production.
    Waidmann M; Allemand Y; Lehmann J; di Genaro S; Bücheler N; Hamann A; Autenrieth IB
    Gut; 2002 Feb; 50(2):170-9. PubMed ID: 11788555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.